Morgan Stanley Call 310 GD 20.12..../ DE000ME76K49 /
27.06.2024 18:01:18 | Изменение-0.020 | Бид22:00:34 | Предложение22:00:34 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.660EUR | -2.94% | - Величина цены спроса: - |
- Величина цены предложения: - |
General Dynamics Cor... | 310.00 USD | 20.12.2024 | Call |
GlobeNewswire
2:00
ROSEN, THE FIRST FILING FIRM, Encourages FutureFuel Corp. Investors to Secure Counsel Before Importa...
GlobeNewswire
1:51
ROSEN, LEADING INVESTOR COUNSEL, Encourages Gritstone bio, Inc. Investors to Secure Counsel Before I...
GlobeNewswire
1:39
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
1:31
PATH INVESTOR ALERT: Edelson Lechtzin LLP Urges UiPath, Inc. (NYSE: PATH) Shareholders to Consult Le...
GlobeNewswire
1:30
ROSEN, A LEADING LAW FIRM, Encourages Charge Enterprises, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
1:17
TMCF President and CEO Dr. Harry L. Williams has released the following statement on the FY25 House ...
GlobeNewswire
1:15
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fastly, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
1:10
Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire
1:00
Worldwide License Agreement for EA1080, Oral Selective α4β7 Integrin Antagonist, Signed between EA P...
GlobeNewswire
0:30
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determinatio...
GlobeNewswire
0:29
Oxford Lane Capital Corp. Prices Public Offering of $100,000,000 8.75% Notes Due 2030
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница